

| PRODUCT | CATHEGORY | STATUS |
|---|---|---|
| ABAMETAPIR | Head Lice Infestation | Ready for validation |
| ALECTINIB | Lung cancer | Early development |
| ATROPINE | Eye surgery | Commercial – DMF |
| AXITINIB | Breast cancer | Early development |
| BEMPEDOIC ACID | Hypercholesterolemia | Under development |
| CLASCOTERONE | Acne | Ready for validation |
| CYSTEAMINE BITARTRATE | Cystinosis | Commercial – DMF |
| CYSTEAMINE HCL | Cystinosis | Ready for validation |
| ETRASIMOD | Ulcerative colitis | Under evaluation |
| OZANIMOD | Multiple sclerosis | Ready for validation |
| PONESIMOD | Multiple sclerosis | Under development |
| RIBOCICLIB | Breast cancer | Under development |
| RUCAPARIB | Ovarian cancer | Early development |
| RUXOLITINIB | Myelofibrosis | Ready for validation |
| SELEGILINE | Parkinson’s disease | Under development |
| TIPIRACIL | Colorectal cancer | Ready for validation |
| VORTIOXETINE | Major depressive disorder | Ready for validation |
|
Development, manufacturing, marketing of the above products is performed in countries where such activities are not in conflict with the existing patents. |
||